-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Rani Therapeutics Holdings, Inc. quarterly and annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q3 2025.
- Rani Therapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $-5,412,000, a 20.2% increase year-over-year.
- Rani Therapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $-28,315,000, a 0.52% decline year-over-year.
- Rani Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $-30,018,000, a 11.6% increase from 2023.
- Rani Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $-33,970,000, a 11.1% decline from 2022.
- Rani Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $-30,588,000, a 267% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)